NALCN Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer Patients

Citation:

Thanou E, Lontra D, Balgouranidou I, Efthimiadou EK, Delipetrou A, Tsaroucha E, Theodosiou M, Georgoulias V, Kotsakis A, Lianidou E, et al. NALCN Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer Patients. Biomolecules [Internet]. 2024;14(12).

Notes:

Export Date: 10 November 2025; Cited By: 0

Website

Contact Details

National and Kapodistrian University of Athens
(+30) 210-7274858
Zografou
Athens, ZipCode 15772
efthim@chem.uoa.gr

<embed>

Recent Publications

Platelet-Rich Plasma (PRP) Mitigates Silver Nanoparticle (AgNP)-Induced Pulmonary Fibrosis via iNOS/CD68/CASP3/TWIST1 Regulation: An Experimental Study and Bioinformatics Analysis †
Dextran-Assisted Biomimetic Fabrication of CdSe:Eu QDs With Enhanced Biocompatibility and Stability
Biochemical and structural characterization of chlorite dismutase enzyme from Pseudomonas aeruginosa

2025 (5)
2024 (5)

Eleni Efthimiadou

Assistant Professor, Chemistry

NALCN Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer Patients

Citation:

Notes:

Contact Details

Recent Publications

Publications per year